{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:47:57Z","timestamp":1775184477530,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009991","name":"Jilin Province Department of Finance","doi-asserted-by":"publisher","award":["JLSRCZX2025-006"],"award-info":[{"award-number":["JLSRCZX2025-006"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijbiomac.2026.150861","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:57:52Z","timestamp":1770796672000},"page":"150861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["E3 ubiquitin ligase DTX3L promotes breast cancer progression by enhancing PKC\u03b1 ubiquitination and inhibiting the p38 MAPK signaling pathway"],"prefix":"10.1016","volume":"349","author":[{"given":"Xiaoxiao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunkuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","article-title":"Current and future burden of breast cancer: global statistics for 2020 and 2040","volume":"66","author":"Arnold","year":"2022","journal-title":"Breast Edinb. Scotl."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.150861_bb0020","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.150861_bb0025","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1073\/pnas.84.11.3685","article-title":"Ubiquitin has intrinsic proteolytic activity: implications for cellular regulation","volume":"84","author":"Fried","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150861_bb0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.tibs.2024.06.006","article-title":"UPS-dependent strategies of protein quality control degradation","volume":"49","author":"M\u00fcller","year":"2024","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150861_bb0035","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1073\/pnas.86.8.2597","article-title":"Involvement of the proteasome in various degradative processes in mammalian cells","volume":"86","author":"Matthews","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.med.50.1.57","article-title":"The ubiquitin-proteasome pathway and pathogenesis of human diseases","volume":"50","author":"Schwartz","year":"1999","journal-title":"Annu. Rev. Med."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.150861_bb0045","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.1016\/S0021-9258(20)82050-X","article-title":"Components of ubiquitin-protein ligase system. Resolution, affinity purification, and role in protein breakdown","volume":"258","author":"Hershko","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.150861_bb0050","doi-asserted-by":"crossref","first-page":"21930","DOI":"10.1074\/jbc.M301157200","article-title":"The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity","volume":"278","author":"Takeyama","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150861_bb0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/prot.24054","article-title":"Fold of the conserved DTC domain in Deltex proteins","volume":"80","author":"Obiero","year":"2012","journal-title":"Proteins"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.molcel.2009.08.019","article-title":"BBAP monoubiquitylates histone H4 at lysine 91 and selectively modulates the DNA damage response","volume":"36","author":"Yan","year":"2009","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150861_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106444","article-title":"DTX3L E3 ligase targets p53 for degradation at poly ADP-ribose polymerase-associated DNA damage sites","volume":"26","author":"Yan","year":"2023","journal-title":"iScience"},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2026.150861_bb0070","article-title":"DTX3L E3 ligase: molecular functions, regulatory mechanisms, and potential as a novel cancer biomarker and therapeutic target","volume":"321","author":"Jiang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1476-4598-13-125","article-title":"DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells","volume":"13","author":"Bachmann","year":"2014","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3892\/ijmm.2017.3023","article-title":"DTX3L is upregulated in glioma and is associated with glioma progression","volume":"40","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Med."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.150861_bb0085","doi-asserted-by":"crossref","first-page":"14290","DOI":"10.18632\/oncotarget.3742","article-title":"Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK\/PI3K\/AKT but not MEK\/ERK pathway","volume":"6","author":"Thang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s10528-023-10451-4","article-title":"DTX3L accelerates pancreatic cancer progression via FAK\/PI3K\/AKT Axis","volume":"62","author":"Chen","year":"2024","journal-title":"Biochem. Genet."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010861","article-title":"Silencing DTX3L inhibits the progression of cervical carcinoma by regulating PI3K\/AKT\/mTOR signaling pathway","volume":"24","author":"Hu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13073-024-01422-4","article-title":"Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis","volume":"16","author":"Li","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31334","article-title":"Lipg signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer","volume":"7","author":"Lo","year":"2018","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41420-023-01771-w","article-title":"PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0115","article-title":"Ononin inhibits tumor bone metastasis and osteoclastogenesis by targeting mitogen-activated protein kinase pathway in breast cancer","volume":"7","author":"Ganesan","year":"2024","journal-title":"Research (Washington, D.C.)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13046-025-03529-x","article-title":"Cancer-associated fibroblast promotes tamoxifen resistance in estrogen receptor positive breast cancer via exosomal LncRNA PRKCQ-AS1\/miR-200a-3p\/MKP1 axis-mediated apoptosis suppression","volume":"44","author":"Wu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150861_bb0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218373120","article-title":"HER2-driven breast cancer suppression by the JNK signaling pathway","volume":"120","author":"Itah","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41420-022-00992-9","article-title":"JAC1 targets YY1 mediated JWA\/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC","volume":"8","author":"Zhai","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5600","key":"10.1016\/j.ijbiomac.2026.150861_bb0135","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science (New York, N.Y.)"},{"issue":"Pt 18","key":"10.1016\/j.ijbiomac.2026.150861_bb0140","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1242\/jcs.00037","article-title":"PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells","volume":"115","author":"Mauro","year":"2002","journal-title":"J. Cell Sci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.150861_bb0145","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/onc.2013.147","article-title":"Protein kinase c\u03b1 suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGF\u03b2 signaling axis","volume":"33","author":"Hill","year":"2014","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150861_bb0150","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101838RRR","article-title":"Protein kinase C \u03b1 and \u03b2 compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation","volume":"36","author":"Teegala","year":"2022","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0155","article-title":"DTX3L induced NLRP3 ubiquitination inhibit R28 cell pyroptosis in OGD\/R injury","volume":"1870","author":"Zhou","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104715","article-title":"Novel strategies in breast cancer management: from treatment to long-term remission","volume":"211","author":"Habibi","year":"2025","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101288","article-title":"Drug resistance in breast cancer: mechanisms and strategies for management","volume":"83","author":"Wu","year":"2025","journal-title":"Drug Resist. Updat."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer - expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150861_bb0185","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.semdp.2022.06.015","article-title":"Update on prognostic and predictive biomarkers of breast cancer","volume":"39","author":"Hou","year":"2022","journal-title":"Semin. Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150861_bb0195","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1042\/BST20220501","article-title":"Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer","volume":"50","author":"Vela-Rodr\u00edguez","year":"2022","journal-title":"Biochem. Soc. Trans."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.150861_bb0200","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/s44318-024-00126-0","article-title":"PARP14 and PARP9\/DTX3L regulate interferon-induced ADP-ribosylation","volume":"43","author":"Kar","year":"2024","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150861_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061913","article-title":"The p38 pathway: from biology to Cancer therapy","volume":"21","author":"Mart\u00ednez-Lim\u00f3n","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0210","doi-asserted-by":"crossref","DOI":"10.1007\/s11030-025-11291-7","article-title":"Advances in targeting p38 MAPK for cancer therapy: insights from molecular pharmacology and medicinal chemistry","author":"Bhole","year":"2025","journal-title":"Mol. Divers."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010370","article-title":"The p38 MAPK components and modulators as biomarkers and molecular targets in cancer","volume":"23","author":"Garc\u00eda-Hern\u00e1ndez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.150861_bb0220","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1038\/s41388-022-02329-3","article-title":"Role of p38 MAP kinase in cancer stem cells and metastasis","volume":"41","author":"Kudaravalli","year":"2022","journal-title":"Oncogene"},{"issue":"29","key":"10.1016\/j.ijbiomac.2026.150861_bb0225","doi-asserted-by":"crossref","first-page":"9744","DOI":"10.3748\/wjg.v20.i29.9744","article-title":"p38\u03b1 MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance","volume":"20","author":"Grossi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.150861_bb0230","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1158\/0008-5472.CAN-05-3676","article-title":"The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma","volume":"66","author":"Hickson","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.150861_bb0235","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tibs.2007.06.007","article-title":"The pathways to tumor suppression via route p38","volume":"32","author":"Han","year":"2007","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.150861_bb0240","first-page":"1684","article-title":"ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)","volume":"63","author":"Aguirre-Ghiso","year":"2003","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.150861_bb0245","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/1078-0432.CCR-13-2823","article-title":"Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival","volume":"20","author":"Zhong","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0250","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.celrep.2018.03.096","article-title":"Mutual stabilization between TRIM9 short isoform and MKK6 potentiates p38 signaling to synergistically suppress glioblastoma progression","volume":"23","author":"Liu","year":"2018","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150861_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2020.151096","article-title":"Glypican-3 (GPC3) inhibits metastasis development promoting dormancy in breast cancer cells by p38 MAPK pathway activation","volume":"99","author":"Guere\u00f1o","year":"2020","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0260","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ijc.28958","article-title":"p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion","volume":"136","author":"Hong","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.150861_bb0265","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/cgt.2012.38","article-title":"HGFK1 inhibits bone metastasis in breast cancer through the TAK1\/p38 MAPK signaling pathway","volume":"19","author":"Yao","year":"2012","journal-title":"Cancer Gene Ther."},{"issue":"47","key":"10.1016\/j.ijbiomac.2026.150861_bb0270","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1038\/s41388-020-01481-y","article-title":"Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0275","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1186\/s12964-024-02000-2","article-title":"Her2 promotes early dissemination of breast cancer by inhibiting the p38 pathway through the downregulation of MAP3K4","volume":"22","author":"Wang","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0280","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10409238.2018.1442408","article-title":"Protein kinase C: perfectly balanced","volume":"53","author":"Newton","year":"2018","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0285","first-page":"E395","article-title":"Protein kinase C: poised to signal, American journal of physiology","volume":"298","author":"Newton","year":"2010","journal-title":"Endocrinol. Metab."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2026.150861_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1515\/bmc-2017-0005","article-title":"Protein kinase C-\u03b1 and the regulation of diverse cell responses","volume":"8","author":"Singh","year":"2017","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ijbiomac.2026.150861_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2020.100769","article-title":"The complexities of PKC\u03b1 signaling in cancer","volume":"80","author":"Black","year":"2021","journal-title":"Advances in Biological Regulation"},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.150861_bb0300","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.ejca.2004.06.027","article-title":"Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma","volume":"40","author":"Ainsworth","year":"2004","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/002215540405200314","article-title":"Immunohistochemical analysis of advanced human breast carcinomas reveals downregulation of protein kinase C alpha","volume":"52","author":"Kerfoot","year":"2004","journal-title":"J. Histochem. Cytochem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150861_bb0310","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/s44319-024-00235-1","article-title":"Ubiquitylation of nucleic acids by DELTEX ubiquitin E3 ligase DTX3L","volume":"25","author":"Zhu","year":"2024","journal-title":"EMBO Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.150861_bb0315","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/jcsm.13544","article-title":"L-carnitine relieves cachexia-related skeletal muscle fibrosis by inducing deltex E3 ubiquitin ligase 3L to negatively regulate the Runx2\/COL1A1 axis","volume":"15","author":"Lu","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.150861_bb0320","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00687-23","article-title":"DTX3L enhances type I interferon antiviral response by promoting the ubiquitination and phosphorylation of TBK1","volume":"97","author":"Huang","year":"2023","journal-title":"J. Virol."},{"issue":"35","key":"10.1016\/j.ijbiomac.2026.150861_bb0325","doi-asserted-by":"crossref","first-page":"20973","DOI":"10.1074\/jbc.271.35.20973","article-title":"Ubiquitination of protein kinase C-alpha and degradation by the proteasome","volume":"271","author":"Lee","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0026-895X(24)13485-2","article-title":"Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin\/proteasome pathway in human fibroblasts","volume":"51","author":"Lee","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0335","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2006.09.163","article-title":"Mutual regulation of conventional protein kinase C and a ubiquitin ligase complex","volume":"351","author":"Nakamura","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.150861_bb0340","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.celrep.2018.06.067","article-title":"Crosstalk between PKC\u03b1 and PI3K\/AKT signaling is tumor suppressive in the endometrium","volume":"24","author":"Hsu","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.150861_bb0345","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11373-005-1210-5","article-title":"Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2","volume":"12","author":"Wen-Sheng","year":"2005","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.150861_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.canlet.2005.07.034","article-title":"Protein kinase C alpha trigger Ras and Raf-independent MEK\/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2","volume":"239","author":"Wen-Sheng","year":"2006","journal-title":"Cancer Lett."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.150861_bb0355","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1158\/0008-5472.CAN-06-0268","article-title":"Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin\/+ mice","volume":"66","author":"Oster","year":"2006","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.150861_bb0360","first-page":"4692","article-title":"Loss of protein kinase Calpha expression may enhance the tumorigenic potential of Gli1 in basal cell carcinoma","volume":"63","author":"Neill","year":"2003","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.150861_bb0365","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1016\/j.apsb.2024.08.003","article-title":"PKC\u03b1 inhibitors promote breast cancer immune evasion by maintaining PD-L1 stability","volume":"14","author":"Yu","year":"2024","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026007877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026007877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:49:04Z","timestamp":1775180944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026007877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":73,"alternative-id":["S0141813026007877"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150861","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E3 ubiquitin ligase DTX3L promotes breast cancer progression by enhancing PKC\u03b1 ubiquitination and inhibiting the p38 MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.150861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150861"}}